Progressive decrease in the level of YAPdeltaCs, prosurvival isoforms of YAP, in the spinal cord of transgenic mouse

Nobutoshi Morimoto1, Makiko Nagai, Kazunori Miyazaki

  • 1Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama University, 2-5-1 Shikata-cho, Okayama, Japan.

Insights

Amyotrophic lateral sclerosis (ALS) involves motor neuron death. This study links ALS progression in mouse models to a decrease in prosurvival YAPdeltaCs and an increase in pro-apoptotic p73, suggesting a novel cell death mechanism.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with unclear cell death mechanisms.
  • Familial ALS (FALS) accounts for 5-10% of cases, with SOD1 mutations in ~20% of FALS patients.
  • Existing cell death pathways like apoptosis and necrosis do not fully explain motor neuron demise in ALS.

Purpose of the Study:

  • To investigate the potential link between motor neuron death in ALS and transcriptional repression-induced atypical death (TRIAD).
  • To examine the roles of YAPdeltaCs and p73 in an established mouse model of ALS.

Main Methods:

  • Utilized G93ASOD1 transgenic mice (Tg) as a model for familial ALS.
  • Analyzed spinal cord tissue from Tg mice at various disease stages.
  • Quantified levels of YAPdeltaCs, FL-YAP, total p73, and phosphorylated p73.

Main Results:

  • YAPdeltaCs levels progressively decreased in Tg mice spinal cords with disease progression.
  • FL-YAP levels remained stable until late symptomatic stages in Tg mice.
  • While total p73 decreased with age, its phosphorylation ratio increased in late-stage symptomatic Tg mice.

Conclusions:

  • The findings suggest that a shift in the balance between YAPdeltaCs and p73, specifically decreasing YAPdeltaCs and increasing p73 phosphorylation, correlates with ALS disease progression.
  • This supports the hypothesis that TRIAD may contribute to motor neuron death in ALS.
  • Further research into TRIAD could reveal new therapeutic targets for ALS.

Related Concept Videos